HK1054682B - 血小板特異性的嵌合性免疫球蛋白及其使用方法 - Google Patents

血小板特異性的嵌合性免疫球蛋白及其使用方法

Info

Publication number
HK1054682B
HK1054682B HK03106368.8A HK03106368A HK1054682B HK 1054682 B HK1054682 B HK 1054682B HK 03106368 A HK03106368 A HK 03106368A HK 1054682 B HK1054682 B HK 1054682B
Authority
HK
Hong Kong
Prior art keywords
platelet
immunoglobulins
specific
methods
chimeric immunoglobulin
Prior art date
Application number
HK03106368.8A
Other languages
English (en)
Other versions
HK1054682A1 (en
Inventor
S Coller Barry
F Weisman Harlan
Original Assignee
Centocor Inc
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22523494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1054682(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Inc, Univ New York State Res Found filed Critical Centocor Inc
Publication of HK1054682A1 publication Critical patent/HK1054682A1/xx
Publication of HK1054682B publication Critical patent/HK1054682B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK03106368.8A 1993-11-05 2003-09-08 血小板特異性的嵌合性免疫球蛋白及其使用方法 HK1054682B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14792893A 1993-11-05 1993-11-05

Publications (2)

Publication Number Publication Date
HK1054682A1 HK1054682A1 (en) 2003-12-12
HK1054682B true HK1054682B (zh) 2006-05-04

Family

ID=22523494

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106368.8A HK1054682B (zh) 1993-11-05 2003-09-08 血小板特異性的嵌合性免疫球蛋白及其使用方法

Country Status (15)

Country Link
EP (2) EP1334730A3 (zh)
JP (1) JPH09504795A (zh)
CN (2) CN1140295C (zh)
AT (1) ATE247980T1 (zh)
AU (2) AU1172495A (zh)
CA (1) CA2175214A1 (zh)
DE (1) DE69433091T3 (zh)
DK (1) DK0725655T4 (zh)
ES (1) ES2204937T5 (zh)
HK (1) HK1054682B (zh)
NZ (2) NZ527820A (zh)
PT (1) PT725655E (zh)
RU (1) RU2158135C2 (zh)
UA (1) UA37249C2 (zh)
WO (1) WO1995012412A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
US5753230A (en) 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
NZ513882A (en) * 1995-06-07 2001-09-28 Centocor Inc Platelet-specific chimeric immunogloulin and method of use thereof
JP2001512480A (ja) * 1997-02-19 2001-08-21 セントコア，インコーポレイテッド 持続的薬物送達およびそれに有用な組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297815C (en) * 1985-06-07 1992-03-24 Barry S. Coller Fibrinogen blocking monoclonal antibody
CA1297816C (en) * 1985-06-14 1992-03-24 Barry S. Coller Platelet function inhibiting monoclonal antibody fragment
KR940009084B1 (ko) * 1988-05-18 1994-09-29 체크 포인트 시스템스, 인코오퍼레이티드 자기 및 공명회로 검출용 안테나 시스템
DE69020548T2 (de) * 1989-04-03 1996-03-07 Centocor Inc Blutplättchenspezifische immunokonjugate.
ATE169227T1 (de) * 1991-09-30 1998-08-15 Biogen Inc Hemmung von gefässverengung unter verwendung von anti-padgem antikörpern.
ES2179824T3 (es) * 1991-12-20 2003-02-01 Yamanouchi Pharma Co Ltd Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.

Also Published As

Publication number Publication date
DE69433091T3 (de) 2009-07-30
JPH09504795A (ja) 1997-05-13
DE69433091T2 (de) 2004-06-03
AU1172495A (en) 1995-05-23
CN1404877A (zh) 2003-03-26
EP1334730A3 (en) 2003-12-03
DK0725655T3 (da) 2004-01-05
ES2204937T5 (es) 2009-07-06
NZ502819A (en) 2002-09-27
EP0725655B2 (en) 2009-04-15
NZ527820A (en) 2005-04-29
HK1054682A1 (en) 2003-12-12
ES2204937T3 (es) 2004-05-01
EP1334730A2 (en) 2003-08-13
CN1230201C (zh) 2005-12-07
UA37249C2 (uk) 2001-05-15
CN1142189A (zh) 1997-02-05
DK0725655T4 (da) 2009-05-18
EP0725655B1 (en) 2003-08-27
EP0725655A1 (en) 1996-08-14
PT725655E (pt) 2004-01-30
CN1140295C (zh) 2004-03-03
CA2175214A1 (en) 1995-05-11
DE69433091D1 (de) 2003-10-02
WO1995012412A1 (en) 1995-05-11
AU8959398A (en) 1999-01-14
ATE247980T1 (de) 2003-09-15
RU2158135C2 (ru) 2000-10-27

Similar Documents

Publication Publication Date Title
HK1044563A1 (zh) 血小板特異的嵌入型免疫球蛋白
MY113497A (en) Peptides and compounds that bind to a receptor
MX9700312A (es) Metodos y composiciones para la coagulacion especifica en vasculatura.
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
IL127509A (en) Kit including a cytoprotective conjugate containing an antibody or antibody fragment specific to an antigen
NZ511956A (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
HK1048496A1 (zh) 應力蛋白及其使用
CA2128511A1 (en) Monomeric and dimeric antibody-fragment fusion proteins
EP0550400A3 (en) Modular assembly of antibody genes, antibodies prepared thereby and use
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
AU1378395A (en) Metal chelators
EP0511306A4 (en) Tumor killing effects of enterotoxins and related compounds
EP0610286A4 (en) Recombinant immunotoxins.
CA2052713A1 (en) Delivery of agents
HK1054682A1 (en) Platelet-specific chimeric immunoglobulin and methods of use therefor
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
WO1996040250A3 (en) Platelet-specific chimeric immunoglobulin and methods of use therefor
DE69020548D1 (de) Blutplättchenspezifische immunokonjugate.
AU2415599A (en) Rantes mutants and therapeutic applications thereof
GB9100741D0 (en) Treatment of disease
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
AU3283693A (en) Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
Wines et al. The Fab/c fragment of IgG produced by cleavage at cyanocysteine residues
GB9715177D0 (en) Medicament